Myeloid Checkpoint Blockade Improves Killing of T-acute Lymphoblastic Leukemia Cells by an IgA2 Variant of Daratumumab
Frontiers in Immunology(2022)
Key words
T-cell acute lymphoblastic leukemia (T-ALL),CD38,daratumumab,IgA,CD47,immunotherapy
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined